Di Pino Alfredo, Oreto Lilia, Di Pino Antonino
Mediterranean Pediatric Cardiology Center, S. Vincenzo Hospital, 98039, Taormina, Italy.
Department of Clinical and Experimental Medicine, University Hospital of Catania, Catania, Italy.
J Interv Card Electrophysiol. 2023 Aug;66(5):1125-1133. doi: 10.1007/s10840-022-01409-4. Epub 2022 Nov 17.
Sudden cardiac death (SCD) may rarely occur among asymptomatic patients with Wolff-Parkinson-White (WPW) pattern. Risk stratification is based on electrophysiological study (EPS). We aimed to evaluate long-term efficacy of such a strategy in preventing SCD.
Retrospective analysis of asymptomatic children with WPW who underwent EPS using isoproterenol. Patients considered at risk had inducible sustained atrial fibrillation or atrioventricular reentry tachycardia (AVRT) associated with the following: (1) accessory pathway (AP) effective refractory period or (2) 1:1 shortest cycle length along the AP or (3) shortest pre-excited R-R interval during AF ≤ 250 ms.
Fifty-one consecutive cases (7-18 years, 12 ± 3) were identified, 40 (78%) with right and 11 (22%) with left AP. Twenty-eight (55%) were classified as high risk (HI) and 23 (45%) as low risk (LO), with no significant differences in demographic characteristics and AP locations. Ablation was performed in 20/28 HI and 11/23 LO patients (p 0.08), with no significant differences in acute success (20/20 versus 10/11, p 0.17) or recurrence (1/20 versus 2/10, p 0.15). Follow-up (46 ± 27 months): ablated patients remained asymptomatic; among the 23 non-ablated, 18 (78%) remained asymptomatic, 5 (22%) were successfully ablated, and 5 (22%) presented events (4 AVRT, 1 SCD). Arrhythmic events did not differ significantly between non-ablated HR and LR (2/8 versus 3/15, p 0.29) and the SCD was in the LO group.
More than 50% asymptomatic WPW children present high-risk AP properties. EPS-based risk stratification using isoproterenol was not able to identify increased risk of future events or SCD.
在无症状的预激综合征(WPW)患者中,心脏性猝死(SCD)可能很少发生。风险分层基于电生理研究(EPS)。我们旨在评估这种策略在预防SCD方面的长期疗效。
对使用异丙肾上腺素进行EPS检查的无症状WPW儿童进行回顾性分析。被认为有风险的患者出现可诱发的持续性心房颤动或房室折返性心动过速(AVRT),并伴有以下情况:(1)旁路(AP)有效不应期或(2)沿AP的1:1最短周期长度或(3)房颤期间最短预激R-R间期≤250毫秒。
共确定了51例连续病例(7至18岁,12±3),40例(78%)为右侧AP,11例(22%)为左侧AP。28例(55%)被归类为高危(HI),23例(45%)为低危(LO),在人口统计学特征和AP位置方面无显著差异。20/28例HI患者和11/23例LO患者接受了消融治疗(p=0.08),在急性成功率(20/20对10/11,p=0.17)或复发率(1/20对2/10,p=0.15)方面无显著差异。随访(46±27个月):接受消融治疗的患者仍无症状;在23例未接受消融治疗的患者中,18例(78%)仍无症状,5例(22%)成功接受了消融治疗,5例(22%)出现了事件(4例AVRT,1例SCD)。未接受消融治疗的高危和低危患者之间的心律失常事件无显著差异(2/8对3/15,p=0.29),且SCD发生在LO组。
超过50%的无症状WPW儿童具有高危AP特性。使用异丙肾上腺素进行基于EPS的风险分层无法识别未来事件或SCD风险的增加。